Apotex Execs Avoid Criminal Charges Under DOJ Deferred Prosecution Agreement
Executive Summary
While former Sandoz and Heritage execs were charged in the government's generic price-fixing probe, Apotex and its employees will apparently escape such fate if they abide by the terms of DOJ agreement; company admits to fixing price of pravastatin and agrees to pay $24.1m criminal penalty.
You may also be interested in...
Teva Gambles Indictment Is Better Than Pleading Guilty To US Price-Fixing Claims
Teva’s market overhang and legal uncertainty intensifies with DOJ charges it conspired to fix generic drug prices. Five other companies have pled guilty and reached deferred prosecution agreements.
Teva Gambles Indictment Is Better Than Pleading Guilty To Price-Fixing Claims
Teva’s market overhang and legal uncertainty intensifies with DOJ charges it conspired to fix generic drug prices. Five other companies have pled guilty and reached deferred prosecution agreements.
Generic Price-Fixing: Sandoz Employee Notebook Provides Evidence For AGs' Third Suit
Complaint names 26 generic dermatologic drug manufacturers and 10 individual executives as defendants, alleging they engaged in a widespread conspiracy to artificially inflate and manipulate prices. State attorneys general say that structural and personnel changes at the companies fostered and facilitated collusion.